{
    "nctId": "NCT03930680",
    "briefTitle": "Prevention of Heart Failure Induced by Doxorubicin with Early Administration of Dexrazoxane",
    "officialTitle": "Prevention of Heart Failure Induced by Doxorubicin with Early Administration of Dexrazoxane in Patients with Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Healthy",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 25,
    "primaryOutcomeMeasure": "Degradation of Topoisomerase 2 b",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women,\n* Age 18-65,\n* Not pregnant, Not currently breast feeding\n* No current illness,\n\nExclusion Criteria:\n\n* Pregnancy, currently breast feeding\n* Current illness,\n* History of cardiac, or renal disease",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}